Vanguard Group
ENZN

Vanguard Group’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Vanguard Group’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,503,258
Closed -$706K – 4170
2016
Q1 		$706K Buy
1,503,258
+25,720
+2% +$12.6K ﹤0.01% 3695
2015
Q4 		$1.01M Buy
1,477,538
+40,374
+3% +$32K ﹤0.01% 3627
2015
Q3 		$1.4M Buy
1,437,164
+38,946
+3% +$47.9K ﹤0.01% 3528
2015
Q2 		$1.68M Buy
1,398,218
+53,115
+4% +$67.7K ﹤0.01% 3479
2015
Q1 		$1.43M Buy
1,345,103
+47,156
+4% +$48.8K ﹤0.01% 3530
2014
Q4 		$1.41M Buy
1,297,947
+12,736
+1% +$13.4K ﹤0.01% 3410
2014
Q3 		$1.39M Buy
1,285,211
+37,396
+3% +$46.2K ﹤0.01% 3409
2014
Q2 		$1.3M Sell
1,247,815
-46,538
-4% -$44.3K ﹤0.01% 3416
2014
Q1 		$1.33M Buy
1,294,353
+22,188
+2% +$22.9K ﹤0.01% 3363
2013
Q4 		$1.48M Sell
1,272,165
-178,709
-12% -$275K ﹤0.01% 3309
2013
Q3 		$2.44M Sell
1,450,874
-331,883
-19% -$614K ﹤0.01% 3057
2013
Q2 		$3.57M Buy
+1,782,757
New +$5.22M ﹤0.01% 2847

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Vanguard Group's ENZN Position: Q2 2016 in Review

Vanguard Group sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 1,503,258 shares — an estimated $706K sold.

Vanguard Group first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $3.57M in Q2 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Vanguard Group reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Vanguard Group sold 1,503,258 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $706K.
  • Vanguard Group first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 12 quarters.
  • Vanguard Group's ENZON PHARMACEUTICALS INC position peaked at $3.57M in Q2 2013.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Vanguard Group's 13F filing for Q2 2016, filed 10 Aug 2016.